πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 102 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10344281

Functionally-modified oligonucleotides and subunits thereof

Sarepta Therapeutics, Inc. Β· Granted Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10337003

Compositions for treating muscular dystrophy

Sarepta Therapeutics, Inc. Β· Granted Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10300149

Compositions for enhancing transport of molecules into cells

Sarepta Therapeutics, Inc. Β· Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10202602

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

Sarepta Therapeutics, Inc. Β· Granted Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10144762

Antibacterial antisense oligonucleotide and method

Sarepta Therapeutics, Inc. Β· Granted Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10106796

Compound and method for treating myotonic dystrophy

Sarepta Therapeutics, Inc. Β· Granted Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10076536

Oligonucleotide analogues targeting human LMNA

Sarepta Therapeutics, Inc. Β· Granted Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10066228

Oligonucleotides for treating expanded repeat diseases

Sarepta Therapeutics, Inc. Β· Granted Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10006031

Antisense composition and method for treating muscle atrophy

Sarepta Therapeutics, Inc. Β· Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9982261

Antisense antiviral compounds and methods for treating a filovirus infection

Sarepta Therapeutics, Inc. Β· Granted Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9944926

Induced exon inclusion in spinal muscle atrophy

Sarepta Therapeutics, Inc. Β· Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9920085

Boronic acid conjugates of oligonucleotide analogues

Sarepta Therapeutics, Inc. Β· Granted Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9862946

Peptide oligonucleotide conjugates

Sarepta Therapeutics, Inc. Β· Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9790499

Functionally-modified oligonucleotides and subunits thereof

Sarepta Therapeutics, Inc. Β· Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9682097

Oligonucleotide analogues targeting human LMNA

Sarepta Therapeutics, Inc. Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9534220

Antisense antibacterial method and compound

Sarepta Therapeutics, Inc. Β· Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9506058

Compositions for treating muscular dystrophy

Sarepta Therapeutics, Inc. Β· Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9499583

Antibacterial antisense oligonucleotide and method

Sarepta Therapeutics, Inc. Β· Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9487786

Immunosuppression compound and treatment method

Sarepta Therapeutics, Inc. Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9469664

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

Sarepta Therapeutics, Inc. Β· Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9453225

Multiple exon skipping compositions for DMD

Sarepta Therapeutics, Inc. Β· Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9447416

Multiple exon skipping compositions for DMD

Sarepta Therapeutics, Inc. Β· Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9447417

Multiple exon skipping compositions for DMD

Sarepta Therapeutics, Inc. Β· Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9434948

Multiple exon skipping compositions for DMD

Sarepta Therapeutics, Inc. Β· Granted Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted